This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Thomas Mackie
Professor Emeritus at University of Wisconsin Madison


“Rock” Mackie has a BSc in Physics (1980) from the University of Saskatchewan and a PhD in Physics (1984) from the University of Alberta. In 1987 he left Canada and came to the University of Wisconsin-Madison and became a full professor in 1998 in the Department of Medical Physics while practicing as a clinical medical physicist and conducting radiotherapy physics research in the Department of Human Oncology.  He was at the UW for 25 years and supervised more than 40 PhD students and co-authored more than 180 peer-reviewed publications. He also had an appointment in Engineering Physics with the UW College of Engineering and was a faculty affiliate in the Department of Biomedical Engineering in the same college. He has been a UW Professor Emeritus since 2012 and an Emeritus Investigator at the Morgridge Institute for Research since 2015. He has been awarded the Coolidge Gold Medal from the AAPM (2014) and the Gold Medal from ASTRO (2019).

Rock Mackie is the Chief Innovation Officer of UW Health and has a long entrepreneurial career both as an academic and since retiring as a professor. He is a co-founder and Chairman of the Board for the Center for the Assessment of Radiological Sciences (CARS), a not-for-profit organization supporting quality in radiation oncology and radiology. In 1992 he co-founded Geometrics Corporation to develop the Pinnacle radiotherapy treatment planning system, which originated from his clinical and research work. Now owned by Philips Medical Corporation, it was once the largest selling radiation therapy treatment planning system in the world. In 1997, Rock co-founded TomoTherapy in 1997, an image-guided intensity modulated radiotherapy company and was its Chairman of the Board from founding to IPO and on to sale to Accuray Corporation in 2011. He is a founding board member of several medical companies including HealthMyne, Asto CT, Leo Cancer Care, Shine Medical Technologies, and OnLume. He is a shareholder in several medical companies including Elucent, IMVD, Image Mover, TAI Diagnostics, Cellectar, Redox, and Oncora. He also serves on the boards or advises several other non-medical companies including BioIonix, Linectra, and SmartUQ.

Speakers at this event